PURPOSE: To evaluate the extent to which intraocular pressure and visual field have been reported as outcomes in randomised controlled trials (also referred to as 'trials') of medical treatments for open-angle glaucoma. METHODS: We identified published reports of trials in a systematic review of medical interventions for open-angle glaucoma our group conducted. We assessed whether intraocular pressure and visual field were reported as trial outcomes and classified them to be either completely or incompletely reported for meta-analysis. We also collected data on the length of time patients were followed and source of funding for the trial. RESULTS: As of March 2014, we identified 401 trials that had enrolled 76 861 participants. Eighty per cent of 401 trials provided complete information on intraocular pressure and 11% of the 401 trials provided complete information on visual field. Only a minority of trials followed patients for at least 1 year. About half of all reports in our study stated that receiving funding from the industry. CONCLUSIONS: Although the vast majority of trials provided sufficient data for meta-analysis of the effect of medical management of open-angle glaucoma on intraocular pressure, relatively few provided data for analysing the effect on visual field. We considered this as missed opportunity because the data were not available for evidence synthesis. Investigators have an obligation to patients and providers to determine the comparative effectiveness of glaucoma interventions in terms of patient-important outcomes and not to waste data that could have been collected in trials. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
PURPOSE: To evaluate the extent to which intraocular pressure and visual field have been reported as outcomes in randomised controlled trials (also referred to as 'trials') of medical treatments for open-angle glaucoma. METHODS: We identified published reports of trials in a systematic review of medical interventions for open-angle glaucoma our group conducted. We assessed whether intraocular pressure and visual field were reported as trial outcomes and classified them to be either completely or incompletely reported for meta-analysis. We also collected data on the length of time patients were followed and source of funding for the trial. RESULTS: As of March 2014, we identified 401 trials that had enrolled 76 861 participants. Eighty per cent of 401 trials provided complete information on intraocular pressure and 11% of the 401 trials provided complete information on visual field. Only a minority of trials followed patients for at least 1 year. About half of all reports in our study stated that receiving funding from the industry. CONCLUSIONS: Although the vast majority of trials provided sufficient data for meta-analysis of the effect of medical management of open-angle glaucoma on intraocular pressure, relatively few provided data for analysing the effect on visual field. We considered this as missed opportunity because the data were not available for evidence synthesis. Investigators have an obligation to patients and providers to determine the comparative effectiveness of glaucoma interventions in terms of patient-important outcomes and not to waste data that could have been collected in trials. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Entities:
Keywords:
Clinical Trial; Epidemiology; Glaucoma; Intraocular pressure; Public health
Authors: David F Garway-Heath; David P Crabb; Catey Bunce; Gerassimos Lascaratos; Francesca Amalfitano; Nitin Anand; Augusto Azuara-Blanco; Rupert R Bourne; David C Broadway; Ian A Cunliffe; Jeremy P Diamond; Scott G Fraser; Tuan A Ho; Keith R Martin; Andrew I McNaught; Anil Negi; Krishna Patel; Richard A Russell; Ameet Shah; Paul G Spry; Katsuyoshi Suzuki; Edward T White; Richard P Wormald; Wen Xing; Thierry G Zeyen Journal: Lancet Date: 2014-12-19 Impact factor: 79.321
Authors: Tianjing Li; Kristina Lindsley; Benjamin Rouse; Hwanhee Hong; Qiyuan Shi; David S Friedman; Richard Wormald; Kay Dickersin Journal: Ophthalmology Date: 2015-10-31 Impact factor: 12.079
Authors: Iain Chalmers; Michael B Bracken; Ben Djulbegovic; Silvio Garattini; Jonathan Grant; A Metin Gülmezoglu; David W Howells; John P A Ioannidis; Sandy Oliver Journal: Lancet Date: 2014-01-08 Impact factor: 79.321
Authors: Laura E Downie; Richard Wormald; Jennifer Evans; Gianni Virgili; Peter R Keller; John G Lawrenson; Tianjing Li Journal: JAMA Ophthalmol Date: 2019-06-01 Impact factor: 7.389
Authors: Leonard A Levin; Mohor Sengupta; Laura J Balcer; Mark J Kupersmith; Neil R Miller Journal: Invest Ophthalmol Vis Sci Date: 2021-11-01 Impact factor: 4.799
Authors: Ian J Saldanha; Kristina B Lindsley; Sarah Money; Hannah J Kimmel; Bryant T Smith; Kay Dickersin Journal: BMC Med Res Methodol Date: 2020-02-11 Impact factor: 4.615